Argenta Announces Integrated Drug Discovery Collaboration with Dr. Reddy's Laboratories Ltd
Argenta will apply its integrated drug discovery platform and expertise for hit-to-lead and lead optimization on multiple Dr. Reddy's discovery targets in pain and inflammation. The aim of the collaboration is to deliver high quality development candidates to support Dr. Reddy's research efforts for proprietary products.
Dr. John Montana, Managing Director of Argenta, commented: "We are excited to be working with Dr. Reddy's in identifying novel and differentiated drug candidates for multiple targets meeting unmet clinical needs in pain and inflammation".
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.